Organo Therapeutics wins SLAS New Product Award
Jens Schwamborn & Javier Jarazo use cutting-edge human-specific mini-brains for the discovery and development of effective drug candidates targeting Parkinson”s disease.
Jens Schwamborn and Javier Jarazo of Organo Therapeutics achieved a new milestone by receiving the SLAS New Product Award for their research on the production of 3D brain organoids. The two scientists are creating 3D brain organoids from stem cells of Parkinson’s patients specifically for the midbrain, which help in the development of new drugs for Parkinson’s. Dr. Jens Schwamborn is a professor at the University of Luxembourg, a neuroscientist, and an expert in stem cell and Parkinson’s research. Dr. Javier Jarazo is an expert in stem cell models, phenotyping screening, and computational data analysis.